期刊文献+

人工肝支持系统治疗慢性重型肝炎时对电解质影响的临床观察 被引量:1

Clinical Observation on Serum Electrolyte in the Treatment of Chronic Severe Hepatitis with Artificial Liver Support System
下载PDF
导出
摘要 目的 :观察慢性重型肝炎患者 CHDF(持续缓慢血液透析滤过 ) +PE(血浆置换 )治疗时对血清电解质的影响情况。方法 :随机选取 5 5例慢性重型肝炎患者 ,其中并发低钾血症 2 1例 ,低钠血症 2 0例 ,低氯血症 2 7例 ,在内科综合治疗的基础上加用日产 KM- 880 0血浆交换仪并联用JUN- 5 0 0血液透析滤过仪进行人工肝治疗 ,观察治疗前后的血清 K+ 、Na+ 、Cl-、HCO3-、Ca+ + 的变化情况。结果 :人工肝治疗前后血清 K+ 、Na+ 、Cl-水平有明显差异 (P<0 .0 5 ) ,HCO3 -、Ca+ + 水平无明显变化 (P>0 .0 5 )。结论 :CHDF+PE治疗慢性重型肝炎可有效纠正电解质紊乱 。 Objective to observe the influence on serum electrolyte in the treatment of chronic severe hepatitis with continuous hemodiafiltration(CHDF) plus plasma exchage(PE).Methods:55 patients with chronic severe hepatitis were selected randomly,of them,21 cases complicated with hypokalemia,20 cases complicated with hyponatremia,27 cases complicated with hypochloraemia.At the base of treatment of medicine,all the patients had received a treatment of an artificial liver support system of KM-880 Plasma exchange device made in Japan together with JUN-500 hemodiafiltration.Before and after the treatment,the serum levels of electrolyte including K +、Na +、Cl -、HCO 3 -、Ca ++ were compared. Results:To compare before,the patients'serum levels of electrolyte K +、Na +、Cl - show significant difference after the treatment(P<0.05),but the serum levels of electrolyte HCO 3 -、Ca ++ have a different result (P>0.05). Conclusions:CHDF plus PE can effectively rectify the disturbance of electrolyte and keep the balance of internal environment on the patients with chronic severe hepatitis.
出处 《透析与人工器官》 2003年第4期36-39,共4页 Chinese Journal of Dialysis and Artificial Organs
基金 广东省重点科技攻磁项目 (课题编号 99No.4 90 5 G)
关键词 人工肝支持系统 治疗 慢性重型肝炎 电解质 持续缓慢血液透析滤过 血浆置换 continuous hemodiafiltration plasma exchange severe hepatitis electrolytes
  • 相关文献

参考文献5

  • 1江元森,陈幼明,姚集鲁,李学俊,曾彩虹,邓友,邓练贤,陆玮伦.人工肝支持系统治疗重型肝炎的疗效评价[J].中华内科杂志,2000,39(2):115-117. 被引量:202
  • 2于仲元主编.血液净化:2版[M].北京:现代出版社,1994.492~551.
  • 3庄鹏,江元森,李学俊,谢俊强,邓友,张绍全,姚集鲁.血液滤过透析联合血浆置换治疗中晚期慢性重型肝炎的临床研究[J].中国血液净化,2002,1(8):27-29. 被引量:11
  • 4Andre A. Kaplan and Murray Epstein,Extracorporeal blood purification in the management of patients with hepatic failure. Seminars in Nephrology,Vol 17. No(November) ,1997,pp576-582.
  • 5Tomohito Sadahiro, Hiroyuki Hirasawa, FCCM;Shigeto Oda, MD,et al. Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure. Crit Care Med,2001 ,vol. 29,No. 7:1386-1392.

二级参考文献7

  • 1[2]Makoto Yoshiba, Kazuaki Inoue, Kazuhiko Sekiyama, et al. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artificial Organs,1996, 20(11): 1169-1172
  • 2[4]Andre A. Kaplan and Murray Epstein. Extracorporeal blood purification in the management of patients with hepatic failure. Seminars in Nephrology, 1997,17(6):pp576-582
  • 3[5]Kazufumi Okamoto, Mitsuro Kurose, Yoshitomo Ikuta,et al, Prolonged Artificial liver support in a child with fulminant hepatic failure.ASAIO Journal,1996,42:233-235
  • 4[6]John A,MD;John MD; David Kramer,MD, et al. Diffusive vs.convective therapy: Effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med, 1998, 26(12):1995-2000
  • 5[7]Tomohito Sadahiro, Hiroyuki Hirasawa, Shigeto Oda, et al. Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure. Crit Care Med,2001,29(7):1386-1392
  • 6[8]Agishi T, Nakagawa y, Teraoka S,et al, Plasma exchange as a rescue strategy for hepatic failure. ASAIO Trans,1994,40:77
  • 7江元森,姚集鲁.人工肝支持系统的研究进展[J].广东医学,1999,20(1):70-71. 被引量:12

共引文献209

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部